Call for Abstract

3rd International Conference on Pharmaceutical Chemistry, will be organized around the theme “Recent Advancements, Innovations and future approaches in the fields of Pharmaceutical Chemistry & Drug Discovery process ”

Pharmaceutical Chemistry 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pharmaceutical Chemistry 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Physicochemical and biological factors that contribute to drug action
  • Track 1-2In vivo and in vitro biotransformations of drugs
  • Track 1-3Synthetic chemistry including combinatorial methods
  • Track 1-4Structure-activity relationships of drug Moiety
  • Track 1-5Process Chemistry Considerations
  • Track 1-6Design of Safer Chemicals and Products
  • Track 1-7Impurities and Impurity Profile Significance in API
  • Track 1-8Global Pharmaceutical Policy
  • Track 1-9Medicinal Radiocompounds or Radiopharmaceuticals
  • Track 1-10Modelling and designing of small compounds
  • Track 2-1Application of Medicinal Chemistry to Pharmacology
  • Track 2-2Computer aided drug design (CADD): Virtual screening and Molecular modeling
  • Track 2-3High-Throughput Screening
  • Track 2-4Design and application of prodrugs
  • Track 2-5Drug-Receptor complex/Interactions
  • Track 2-6Molecular modification of known drugs
  • Track 2-7Prodrugs Studies
  • Track 2-8Molecular mechanics
  • Track 3-1Discovery of biomolecules through metagenomics
  • Track 3-2Chemical approaches to stem-cell biology
  • Track 3-3Metal complexes in medicine
  • Track 3-4Bioorganic and Bioinorganic Chemistry
  • Track 3-5Synthetic biology
  • Track 3-6Enzymology
  • Track 3-7Genome Analysis
  • Track 3-8Chemical and Molecular dynamics
  • Track 3-9Applications of Chemical Biology in Drug Discovery
  • Track 4-1Nanobiopharmaceutics
  • Track 4-2Synthesis of Vaccines, blood and blood components
  • Track 4-3Recombinant therapeutic protein, and living cells used in cell therapy
  • Track 4-4Large-scale production: Transgenics
  • Track 4-5Allergenics and somatic cells
  • Track 4-6Biologics: Sugars, proteins, or nucleic acids
  • Track 4-7Medical devices
  • Track 5-1Biosynthetic Mechanisms
  • Track 5-2Prostaglandins and Steriods
  • Track 5-3Alkaloids and Terpenes
  • Track 5-4Synthesis of Amino Acids
  • Track 5-5Peptides & Proteins
  • Track 5-6The Primary Structure of DNA
  • Track 5-7The Secondary & Tertiary Structures of DNA
  • Track 5-8RNA and Protein Synthesis
  • Track 5-9Isolation and Structural elucidation of Natural Products
  • Track 6-1Generating human proteome antibodies via phage display and directed evolution
  • Track 6-2Classical or Quantum mechanic
  • Track 6-3Probing and modulating membrane proteins
  • Track 6-4De novo design of catalytic and membrane proteins
  • Track 6-5Creating fluorescent probes targeting the genome and key bio-pathways
  • Track 6-6Investigating cellular interactions in tissues
  • Track 6-7Globally analyzing and dissecting apoptosis
  • Track 6-8Proximity tagging of protein-protein interactions
  • Track 6-9Monitoring enzyme activity and disease biomarkers
  • Track 7-1The Metrics of Green Chemistry
  • Track 7-2Green Chemistry and Sustainability
  • Track 7-3Designing Sustainable Solutions
  • Track 7-4Principles Applied in Green Chemistry
  • Track 7-5Green Chemistry Focuses on Inherent Hazards
  • Track 7-6Green Chemistry Tackles the Grand Challenges
  • Track 7-7Adverse Effects of Chemicals on Health and the Environment
  • Track 7-8Green Chemistry Problems
  • Track 8-1In-Silico molecular design software and tools
  • Track 8-2Structure based drug design
  • Track 8-3Ligand-based Drug Design
  • Track 8-4Rational Drug Design
  • Track 8-5De Novo Ligand design
  • Track 8-6Computer-Assisted Drug Design
  • Track 8-7Molecular modelling and drug design
  • Track 8-8Computer graphics in drug design
  • Track 9-1Drug Delivery using Nanotechnology
  • Track 9-2Identification and validation of (emerging) drug targets
  • Track 9-3Beaded Delivery Systems
  • Track 9-4Liposomal and Target Delivery System
  • Track 9-5Other Controlled Drug Delivery Systems
  • Track 9-6Thin film drug delivery
  • Track 9-7Acoustic targeted drug delivery
  • Track 9-8Neural drug delivery systems
  • Track 9-9Drug carrier
  • Track 9-10Strategies for drug delivery to the brain
  • Track 10-1Hit to lead
  • Track 10-2Lead identification and optimization
  • Track 10-3Chemical biology approach to drug discovery
  • Track 10-4Plant derived drugs in drug discovery
  • Track 10-5Computer aided drug models in drug discovery
  • Track 10-6Drug transporters in drug discovery
  • Track 10-7A novel paradigm of drug discovery
  • Track 10-8Clinical Drug Development
  • Track 11-1Catalyst: Acid and Base Catalyzed Reactions
  • Track 11-2Organometallic Reagents and Compounds
  • Track 11-3Electrophilic and Nucleophilic Substitution
  • Track 11-4Molecular Rearrangements
  • Track 11-5Free-Radical Reactions
  • Track 11-6Transition Metal Catalysis
  • Track 11-7Redox reactions
  • Track 11-8Reactions at ligands
  • Track 11-9Characterization of inorganic compounds
  • Track 11-10Synthetic inorganic chemistry
  • Track 12-1Nomenclature of Heterocyclic Chemistry
  • Track 12-2Classification of Heterocyclic Chemistry
  • Track 12-3Functional Group Chemistry
  • Track 12-4Reations involved in Heterocyclic chemistry
  • Track 12-5General Strategies for Heterocycle Synthesis
  • Track 12-6Three-Membered Heterocycles: Synthesis and its Activity
  • Track 12-7Four-Membered Heterocycles: Synthesis and its Activity
  • Track 12-8Five-Membered Heterocycles: Synthesis and its Activity
  • Track 12-9Six-Membered Heterocycles: Synthesis and its Activity
  • Track 12-10Some Polycyclic Heterocycles Compounds: Synthesis and its Activity
  • Track 13-1Design, manufacture and use of efficatious dosage forms
  • Track 13-2Types of Formulation: Enteral, Parenteral and Topical
  • Track 13-3Water-miscible formulations
  • Track 13-4Other formulations
  • Track 13-5Pesticide formulation
  • Track 13-6Recent Developments in Dosage Form Design
  • Track 13-7Establishing the Bioequivalence of Pharmaceutical Products
  • Track 14-1Various Separation Techniques
  • Track 14-2Titrimetry and X-ray Crystallography
  • Track 14-3UPLC and HPLC
  • Track 14-4Gravimetric analysis
  • Track 14-5Radioanalytical chemistry
  • Track 14-6Chromatography techniques
  • Track 14-7NMR Spectroscopy
  • Track 14-8Spectroscopy: UV, Mass Spectroscopy and other Spectroscopies techniques
  • Track 14-9Electroanalytical methods: Potentiometry and voltammetry
  • Track 14-10Mass Spectrometry
  • Track 15-1Pharmaceutical Processing Equipment
  • Track 15-2Pharmaceutical Machinery: Tableting, Tube Filling, Liquid Filling, Labeling
  • Track 15-3Pharmaceutical Machinery: Cartoning and Packaging
  • Track 15-4Pharmaceutical Machinery: Standards
  • Track 15-5Pharmaceutical Machinery: Technology
  • Track 15-6Pharmaceutical Manufacturing Equipment
  • Track 15-7Laboratory & Quality Control Equipment
  • Track 15-8Pharmaceutical Machinery: Global Market
  • Track 16-1Pharmacological in vitro and in vivo investigations
  • Track 16-2Toxicology and Pharmacogenomics
  • Track 16-3Biomolecular Interactions and Thermodynamic
  • Track 16-4Bioassay and Dose effect relationships
  • Track 16-5Drug-receptor interactions on the molecular level
  • Track 16-6Drug Transport across Biological Membranes
  • Track 16-7Various ScreeningMethods
  • Track 16-8Enzyme Inhibitors
  • Track 16-9Cancer Therapy
  • Track 17-1Molecular Biotechnology: From DNA Sequence to Therapeutic Protein
  • Track 17-2Production and Purification of Recombinant Proteins
  • Track 17-3Immunogenicity of Therapeutic Proteins
  • Track 17-4Economic Considerations in Medical Biotechnology
  • Track 17-5Monoclonal Antibodies in Various Diseases
  • Track 17-6Biomolecules used to develop targeted drug therapies
  • Track 17-7Biomolecules that elicit specific ligand-receptor interactions
  • Track 17-8Oligopeptides and Nucleic acids
  • Track 17-9Design of proteins
  • Track 18-1Nanomedicine
  • Track 18-2Nanotechnology
  • Track 18-3Nanofabrications, Nano Fluidics, Nano Robotics, Nano Drugs
  • Track 18-4Emerging fields of Nanomedicine and Nanotechnology.
  • Track 19-1Pharmacotoxicology
  • Track 19-2Hospital Pharmacy& Health practice
  • Track 19-3Specialist Roles in Pharmacy
  • Track 19-4Conference Highlights Biopharmaceutics Clinical Drug Development and Therapeutics Clinical Pharmacology Clinical Pharmacy: Activities and Prescriptions